Literature DB >> 20532967

Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.

Paul Eggleton1, Lorna W Harries, Giada Alberigo, Paul Wordsworth, Nick Viner, Richard Haigh, Suzanne Donnelly, Hugh W Jones, Ian C Chikanza, Thomas W E O'Conner, Alasdair E R Thomson, Paul G Winyard.   

Abstract

INTRODUCTION: Systemic lupus erythematosus (SLE) and rheumatoid arthritis have complex genetic traits, but in both autoimmune diseases, dysfunctional apoptosis appears to play a part in disease pathology. This study examined the levels of in vitro apoptosis in lymphocytes from healthy, rheumatoid arthritis (RA) and SLE individuals and related observed differences to their lymphocyte apoptosis gene profiles.
MATERIALS AND METHODS: Lymphocytes were assessed for cell death by nuclear pyknosis and DNA fragmentation. Control, SLE and RA apoptosis gene profiles were obtained by quantitative real-time polymerase chain reaction (QRT-PCR) analysis. RESULTS AND DISCUSSION: The mean levels of pyknosis in RA and SLE freshly isolated lymphocytes were significantly higher than in control lymphocytes. Ninety-three apoptosis genes were analysed by QRT-PCR of mRNA from RA, SLE and healthy lymphocytes. We identified significant differences (p < 0.05) in the expression of the same 11 of 93 and two of 93 apoptotic genes in individual SLE and RA patients tested as compared with controls.
CONCLUSION: We propose that similarly altered expression of specific apoptotic regulatory genes (e.g., the death effector domain-containing DNA-binding protein and apoptosis-associated speck-like protein containing a CARD) occurs in the lymphocytes of individual patients with SLE or RA that may influence the extent and rate of spontaneous apoptosis in these autoimmune conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532967     DOI: 10.1007/s10875-010-9429-y

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  52 in total

Review 1.  Cell death in rheumatoid arthritis.

Authors:  Adelheid Korb; Hermann Pavenstädt; Thomas Pap
Journal:  Apoptosis       Date:  2009-04       Impact factor: 4.677

2.  Ultrastructural characteristics of nucleated cells in bone marrow of patients with acquired aplastic anemia.

Authors:  Yong-Xin Ru; Xiao-Fan Zhu; Jing-Tao Gao; Hui-Jun Wang; Shi-Xuan Zhao; Min Feng; Jin-Hua Liu; En-Bing Liu; Yu-Mei Chen; Yi-Zhou Zhen
Journal:  Ultrastruct Pathol       Date:  2008 May-Jun       Impact factor: 1.094

Review 3.  Apoptosis in rheumatoid arthritis: a novel pathway in the regulation of synovial tissue.

Authors:  K Nishioka; T Hasunuma; T Kato; T Sumida; T Kobata
Journal:  Arthritis Rheum       Date:  1998-01

4.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Inhibition of T cell apoptosis in the rheumatoid synovium.

Authors:  M Salmon; D Scheel-Toellner; A P Huissoon; D Pilling; N Shamsadeen; H Hyde; A D D'Angeac; P A Bacon; P Emery; A N Akbar
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

6.  Induction of mitochondrion-mediated apoptosis of CHO cells by tripchlorolide.

Authors:  Yan Ren; Lei Xiong; Jia Rui Wu
Journal:  Cell Res       Date:  2003-08       Impact factor: 25.617

Review 7.  Switching anti-TNF-alpha agents: what is the evidence?

Authors:  Alan R Erickson; Ted R Mikuls
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

8.  Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment.

Authors:  Simon Brown; Isabelle Heinisch; Ewan Ross; Kate Shaw; Chris D Buckley; John Savill
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

9.  Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.

Authors:  Marieke J H Coenen; Erik J M Toonen; Hans Scheffer; Timothy R D J Radstake; Pilar Barrera; Barbara Franke
Journal:  Pharmacogenomics       Date:  2007-07       Impact factor: 2.533

10.  Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; Natalia Soria; Diana Galiana; Laura Bertolaccini; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Medicine (Baltimore)       Date:  2007-07       Impact factor: 1.889

View more
  9 in total

1.  P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.

Authors:  Jijun Zhao; Hongyue Wang; Chao Dai; Hongyang Wang; Hui Zhang; Yuefang Huang; Shuang Wang; Felicia Gaskin; Niansheng Yang; Shu Man Fu
Journal:  Arthritis Rheum       Date:  2013-12

2.  Increased autophagy in CD4+ T cells of rheumatoid arthritis patients results in T-cell hyperactivation and apoptosis resistance.

Authors:  Jorg van Loosdregt; Maura Rossetti; Roberto Spreafico; Maryam Moshref; Merissa Olmer; Gary W Williams; Pavanish Kumar; Dana Copeland; Ken Pischel; Martin Lotz; Salvatore Albani
Journal:  Eur J Immunol       Date:  2016-10-05       Impact factor: 5.532

3.  Isoflurane attenuates murine lupus nephritis by inhibiting NLRP3 inflammasome activation.

Authors:  Yi Yuan; Zhangsuo Liu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Expression of heat shock protein 70 in lung tissues of acute paraquat poisoned rats and intervention of ulinastatin.

Authors:  Zhi-Jian Zhang; Cong-Yang Zhou; Ya-Juan Luo; Hua-Wei Xiong
Journal:  World J Emerg Med       Date:  2010

5.  Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment.

Authors:  P Conigliaro; P Triggianese; C Perricone; M S Chimenti; G Di Muzio; E Ballanti; M D Guarino; B Kroegler; G Gigliucci; S Grelli; R Perricone
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs.

Authors:  Lihua Shi; Zhe Zhang; Angela M Yu; Wei Wang; Zhi Wei; Ehtisham Akhter; Kelly Maurer; Patrícia Costa Reis; Li Song; Michelle Petri; Kathleen E Sullivan
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

7.  Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection.

Authors:  Kelly M Shepardson; Anupam Jhingran; Alayna Caffrey; Joshua J Obar; Benjamin T Suratt; Brent L Berwin; Tobias M Hohl; Robert A Cramer
Journal:  PLoS Pathog       Date:  2014-09-25       Impact factor: 6.823

8.  Lymphocytes from rheumatoid arthritis patients have elevated levels of intracellular peroxiredoxin 2, and a greater frequency of cells with exofacial peroxiredoxin 2, compared with healthy human lymphocytes.

Authors:  Katalin É Szabó-Taylor; Paul Eggleton; Carly A L Turner; M Letizia Lo Faro; Joanna M Tarr; Sára Tóth; Matt Whiteman; Richard C Haigh; Jennifer A Littlechild; Paul G Winyard
Journal:  Int J Biochem Cell Biol       Date:  2012-04-28       Impact factor: 5.085

9.  Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus.

Authors:  Vassilis L Souliotis; Konstantinos Vougas; Vassilis G Gorgoulis; Petros P Sfikakis
Journal:  Arthritis Res Ther       Date:  2016-08-04       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.